Neo-Poly-Bac Interactions
There are 51 drugs known to interact with Neo-Poly-Bac (bacitracin / hydrocortisone / neomycin / polymyxin b ophthalmic), along with 2 disease interactions. Of the total drug interactions, 1 is major, and 50 are moderate.
- View all 51 medications that may interact with Neo-Poly-Bac
- View Neo-Poly-Bac disease interactions (2)
Most frequently checked interactions
View interaction reports for Neo-Poly-Bac (bacitracin / hydrocortisone / neomycin / polymyxin b ophthalmic) and the medicines listed below.
- acetaminophen / codeine
- acetaminophen / oxycodone
- acetaminophen / pseudoephedrine
- acyclovir
- Advair Diskus (fluticasone / salmeterol)
- albuterol
- Allegra (fexofenadine)
- Alphagan (brimonidine ophthalmic)
- Ambien (zolpidem)
- amlodipine
- amoxicillin / clavulanate
- Anoro Ellipta (umeclidinium / vilanterol)
- aspirin
- Atarax (hydroxyzine)
- Ativan (lorazepam)
- Azopt (brinzolamide ophthalmic)
- Benadryl (diphenhydramine)
- benzonatate
- benztropine
- betamethasone / clotrimazole topical
- Breo Ellipta (fluticasone / vilanterol)
- bupropion
- Dexilant (dexlansoprazole)
- furosemide
- metoprolol
- montelukast
- omeprazole
- prednisone
- propranolol
- Vitamin B12 (cyanocobalamin)
Neo-Poly-Bac disease interactions
There are 2 disease interactions with Neo-Poly-Bac (bacitracin / hydrocortisone / neomycin / polymyxin b ophthalmic) which include:
More about Neo-Poly-Bac (bacitracin / hydrocortisone / neomycin / polymyxin b ophthalmic)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: ophthalmic steroids with anti-infectives
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.